With a population of 1.3 billion people and a rapidly expanding economy, China has recently risen to become the third largest pharmaceutical market globally. Although many of the drugs in the current market are either generic versions or developed outside China, several multinational pharmaceutical companies have now located research and development (R&D) centres in China, and Chinese pharmaceutical companies are increasingly focusing on innovative drug R&D. Furthermore, the Chinese government implemented a special drug R&D funding programme in which $6 billion was invested from 2011 to 2015. 

However, information on the output of innovative drug R&D in China is limited. With the aim of addressing this issue, Bioon's 2018 International Forum on Innovative Drug R&D will be hold, to promote the healthy and rational growth of China's pharmaceutical industry.

This forum is one of the top-ranked meetings in the field of innovative drug R&D in China. Through participating in it, you can learn more about the processing of technologies, the whole industry and the market of innovative drugs, rare diseases, orphan drug development, neonatal genetic diseases in China. Welcome to this academic banquet! Bioon will try our best to provide an excellent platform for you to communicate with China's first-class experts and senior managers, as well as to expand your business in China!